# US 2013/0274121 A1 · Diagnostic Method

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0274121 A1
- Document ID: US20130274121A1
- Status: Published application
- Kind: A1
- Application number: 13/700,025
- Filed: 2011-05-25
- Published: 2013-10-17
- Earliest claimed: 2010-05-25
- Assignees: National University of Ireland,Galway a university
- Inventors: Kate Mary Reddington; Thomas Gerard Barry; Justin Joseph O'Grady; Terence James Smith
- Web page: https://patentgrep.com/patent/US20130274121A1

## CPC

- C12Q 1/689: for bacteria
- C12Q 1/6883: for diseases caused by alterations of genetic material
- C12Q 1/686: Polymerase chain reaction [PCR]
- C12Q 2600/158: Expression markers
- C12Q 2600/16: Primer sets for multiplex assays
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

The present invention relates to a multiplex in vitro nucleic acid amplification method for identifying a species of the Mycobacterium tuberculosis complex present in a sample. The method includes detecting the presence or absence of a plurality of nucleic acid molecule targets in the sample in one reaction, wherein at least one of the nucleic acid molecule targets is present in the genome of one or more, but not all, of the species of the Mycobacterium tuberculosis complex. The invention also includes kits containing primers or probes for conducting this method, nucleic acids useful for performing this method and diagnostic techniques using these nucleic acids.

## Claims

### Claim at position 1

-136. (canceled)

### Claim 137

A multiplex in vitro nucleic acid amplification method for identifying which specific species of the Mycobacterium tuberculosis complex is present in a sample, wherein the method comprises detecting the presence or absence of a plurality of nucleic acid molecule targets in the sample, wherein the nucleic acid molecule targets are present in the genome of one or more, but not all, of the species of the Mycobacterium tuberculosis complex, and wherein the method distinguishes between the following Mycobacterium tuberculosis complex species: Mycobacterium tuberculosis; Mycobacterium canettii; Mycobacterium africanum clade 1; Mycobacterium bovis; Mycobacterium bovis BCG; Mycobacterium caprae; Mycobacterium africanum clade 2; Mycobacterium pinnipedii; and Mycobacterium microti.

### Claim 138 (depends on 137)

The multiplex in vitro nucleic acid amplification method of claim 137 wherein Mycobacterium tuberculosis, Mycobacterium canettii, and Mycobacterium africanum clade 1 are distinguished in a first multiplex reaction, and Mycobacterium bovis, Mycobacterium bovis BCG, Mycobacterium caprae, and Mycobacterium africanum clade 2 are distinguished in a second multiplex reaction, and Mycobacterium pinnipedii, and Mycobacterium microti are distinguished by combining the results of the first multiplex reaction with the results of the second multiplex reaction.

### Claim 139 (depends on 137)

The multiplex in vitro nucleic acid amplification method of claim 137 wherein the plurality of nucleic acid molecule targets comprise a region of: RDcanetti1, SEQ ID NO: 78; wbbl1, SEQ ID NO: 1; RD713, SEQ ID NO: 137; MTC lepA, SEQ ID NO: 47; lpqT, SEQ ID NO: 109; M. caprae lepA, SEQ ID NO: 76; RD1, SEQ ID NO: 141; and RD701, SEQ ID NO: 132.

### Claim 140 (depends on 139)

The multiplex in vitro nucleic acid amplification method of claim 139, wherein the first multiplex reaction detects the presence or absence of nucleic acid molecule targets comprising: RDcanetti1, SEQ ID NO: 78; wbbl1, SEQ ID NO: 1; RD713, SEQ ID NO: 137; and MTC lepA, SEQ ID NO: 47, and wherein the second multiplex reaction detects the presence or absence of nucleic acid molecule targets comprising: lpqT, SEQ ID NO: 109; M. caprae lepA, SEQ ID NO: 76; RD1, SEQ ID NO: 141; and RD701, SEQ ID NO: 132.

### Claim 141

A multiplex in vitro nucleic acid amplification method for identifying a species of the Mycobacterium tuberculosis complex present in a sample, wherein the method comprises detecting the presence or absence of a plurality of nucleic acid molecule targets in the sample in one reaction, wherein at least one of the nucleic acid molecule targets is present in the genome of one or more, but not all, of the species of the Mycobacterium tuberculosis complex.

### Claim 142 (depends on 141)

The multiplex in vitro nucleic acid amplification method of claim 141 wherein the method comprises a multiplex PCR.

### Claim 143 (depends on 141)

The method of claim 141 wherein the method comprises detecting a plurality of nucleic acid molecules which, in combination, are unique in their presence or absence to Mycobacterium tuberculosis; and/or Mycobacterium canettii; and/or Mycobacterium africanum clade 1; optionally comprising the use of primers or probes specific for a nucleic acid sequence that is not present in both M. tuberculosis, and M. canettii; and/or wherein the primers or probes are specific for a nucleic acid sequence that is present in M. canettii but is not present in M. tuberculosis; optionally comprising the use of primers or probes specific for a nucleic acid sequence that is not present in more than one of M. tuberculosis, M. canettii and M. africanum clade 1; optionally wherein the primers or probes are specific for a nucleic acid sequence that is present in M. canettii but is not present in M. tuberculosis or M. africanum clade 1; optionally comprising the use of primers or probes specific for a nucleic acid sequence that is present in both M. tuberculosis and M. canettii.

### Claim 144 (depends on 143)

The method of claim 143 wherein the nucleic acid comprises a region of RDcanetti1, SEQ ID NO: 78; optionally wherein the primers comprise SEQ ID NO: 103 and SEQ ID NO: 105; optionally wherein the probe comprises SEQ ID NO: 104.

### Claim 145 (depends on 143)

The method of claim 143 comprising the use of primers or probes specific for a nucleic acid sequence that is present in all three of M. tuberculosis, M. canettii and M. africanum clade 1; optionally wherein the nucleic acid comprises a region of wbbl1, SEQ ID NO: 1; optionally wherein the primers comprise SEQ ID NO: 97 and SEQ ID NO: 99; optionally wherein the probe comprises SEQ ID NO: 98.

### Claim 146 (depends on 143)

The method of any of claim 143 comprising the use of primers or probes specific for a nucleic acid sequence that is present in M. africanum clade 1 but is not present in M. tuberculosis or M. canettii; optionally wherein the nucleic acid comprises a region of RD713, SEQ ID NO: 137; optionally wherein the primers comprise SEQ ID NOs: 167 and 168; optionally wherein the probe comprises SEQ ID NO: 169.

### Claim 147

The method of any preceding claim comprising the use of primers or probes specific for lepA, SEQ ID NO: 47; optionally wherein the primers comprise SEQ ID NOs: 164 and 165; optionally wherein more than one probe specific for lepA is used; optionally wherein at least one of the probes specific for lepA does not significantly bind to nucleic acid amplified from a member of the Mycobacterium tuberculosis complex; optionally wherein the probe comprises SEQ ID NO: 173.

### Claim 148 (depends on 141)

The method of claim 141 wherein the method comprises detecting a plurality of nucleic acid molecules which, in combination, are unique in their presence or absence to Mycobacterium bovis; and/or Mycobacterium bovis BCG; and/or Mycobacterium caprae; and/or Mycobacterium africanum clade 2; and/or Mycobacterium pinnipedii; and/or Mycobacterium microti.

### Claim 149 (depends on 148)

The method of claim 148 wherein the primers or probes are specific for a nucleic acid sequence that is present in all three of M. bovis, M. bovis BCG and M. caprae; optionally wherein the nucleic acid comprises a region of lpqT, SEQ ID NO: 109; optionally wherein the primers comprise SEQ ID NOs: 158 and 159; optionally wherein the probe comprises SEQ ID NO: 160.

### Claim 150 (depends on 148)

The method of claim 148 wherein the primers or probes are specific for a nucleic acid sequence that is present in M. caprae but is not present in M. bovis or M. bovis BCG; optionally wherein the nucleic acid comprises a region of M. caprae lepA, SEQ ID NO: 76; optionally wherein the primers comprise SEQ ID NOs: 164 and 165; optionally wherein the probe comprises SEQ ID NO: 166.

### Claim 151 (depends on 148)

The method of claim 148 wherein the primers or probes are specific for a nucleic acid sequence that is deleted in M. bovis BCG and M. microti but is present in M. bovis, M. caprae and M. pinnipedii; optionally wherein the nucleic acid comprises a region of RD1, SEQ ID NO: 141; optionally wherein the primers comprise SEQ ID NOs: 161 and 162; optionally wherein the probe comprises SEQ ID NO: 163.

### Claim 152 (depends on 148)

The method of claim 148 wherein the primers or probes are specific for a nucleic acid sequence that is present in M. africanum clade 2 but is not present in M. bovis, M. bovis BCG, M. caprae, M. microti or M. pinnipedii; optionally wherein the nucleic acid comprises a region of RD701, SEQ ID NO: 132; optionally wherein the primers comprise SEQ ID NOs: 170 and 171; optionally wherein the probe comprises SEQ ID NO: 172.

### Claim 153 (depends on 141)

The method of claim 141 wherein the primers or probes are specific for an IAC; optionally wherein the nucleic acid comprises a region of lepA, SEQ ID NO: 84; optionally wherein the primers comprise SEQ ID NOs: 164 and 165; optionally wherein the probe comprises SEQ ID NO: 107.

### Claim 154 (depends on 153)

The method of claim 153 wherein the nucleic acid comprises a region of MSMEG—0660, SEQ ID NO: 135; optionally wherein the primers comprise SEQ ID NOs: 155 and 156; optionally wherein the probe comprises SEQ ID NO: 157.

### Claim 155

A kit comprising a set of primers and probes which are specific for a plurality of nucleic acid molecule targets, wherein at least one of the nucleic acid molecule targets is present in the genome of one or more, but not all, of the species of the Mycobacterium tuberculosis complex; optionally comprising primers or probes specific for a region of RDcanetti1, SEQ ID NO: 78; and/or primers or probes specific for a region of wbbl1, SEQ ID NO: 1; and/or primers or probes specific for a region of RD713, SEQ ID NO: 137; and/or primers or probes specific for MTC lepA, SEQ ID NO: 47; and/or primers or probes specific for a region of lpqT, SEQ ID NO: 109; and/or primers or probes specific for a region of M. caprae lepA, SEQ ID NO: 76; and/or primers or probes specific for a region of RD1, SEQ ID NO: 141; and/or primers or probes specific for a region of RD701, SEQ ID NO: 132; and/or primers or probes specific for a region of lepA, SEQ ID NO: 68; and/or primers or probes specific for a region of MSMEG—0660, SEQ ID NO: 135.

### Claim 156

A diagnostic technique for identifying a species of the Mycobacterium tuberculosis complex comprising hybridising sample nucleic acid molecules to one or more nucleic acid molecules which comprise a sequence selected from the group consisting of SEQ ID NOs: 1-78 or 109-154 and sequences complementary to SEQ ID NOs: 1-78 or 109-154; optionally wherein the hybridisation occurs on a microarray.
